COLCITEX TABLET 0.6 MG [SIN12301P]
Active ingredients: COLCITEX TABLET 0.6 MG
Last updated 24 April 2026
Product Info
COLCITEX TABLET 0.6 MG
[SIN12301P]
Product information
Active Ingredient and Strength | COLCHICINE - 0.6 MG |
Dosage Form | TABLET |
Manufacturer and Country | THE UNITED DRUG (1996) CO LTD - THAILAND |
Registration Number | SIN12301P |
Licence Holder | ALCARE PHARMACEUTICALS PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | M04AC01 |
Prescription-only Medicines with Exemptions for Supply without Prescription | NA |
Indication
Indications and Usage :
Colcitex is indicated for the treatment of gout. It is effective in relieving the pain of acute attacks, especially if therapy is begun early in the attack and in adequate dosage. Many therapists use Colcitex as interval therapy to prevent acute attacks of gout. It has no effect on nongouty arthritis or on uric acid metabolism.
Dosing
Dosage and administration :
Colcitex should be started at the first warning of an acute attack; a delay of a few hours impairs its effectiveness. The usual adult dose is 1 or 2 tablets initially, followed by 1 tablet every 1 to 2 hours until pain is relieved or nausea, vomiting, or diarrhea develops. Some physicians prescribe 2 tablets every 2 hours. Since the number of doses required may range from 6 to 16, the total dosage is variable. As interval treatment, 1 tablet may be taken 1 to 4 times a week for the mild or moderate case, once or twice daily for the severe case. If an acute attack of gout occurs while the patient is taking Colcitex as maintenance therapy, an alternative drug should be instituted in preference to increasing the dose of Colcitex.
Contraindications
Contraindications :
Colcitex is contraindicated in patients with gout who also have serious gastrointestinal, renal, hepatic, or cardiac disorders.
Colcitex should not be given in the presence of combined renal and hepatic disease.